Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Phase II Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymic Epithelial Malignant Tumor Received R2 Resection

NCT06311955 is registered in ClinicalTrials.gov with Jian Chen as lead sponsor.

NCT NCT06311955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06311955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Phase II Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymic Epithelial Malignant Tumor Received R2 Resection
Lead sponsor
Jian Chen
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2025
Completion date
February 28, 2029
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carbon ion radiotheray, heavy ion radiotherapy, radiotherapy side effect, thymic epithelial tumor